J.G.Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Net loss reportedEBITDA margin compressionResults restatedExceptional itemResults View source PDF Explain this filing

JGCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹418.00

prior close

₹415.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-5.5% vs market

Commodity Chemicals peers, median of 50sector-0.6%-5.2% vs sector

On the reaction day the stock moved 5.5 pts less than Nifty Microcap 250 and 5.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.9

10m

-4.8

15m

-4.6

30m

-3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8-0.4-5.5-0.6-5.2

Next day

-7.2-1.7-5.5-1.7-5.5

-7.4-1.3-6.1-1.2-6.2

-5.3-0.7-4.6-0.1-5.2

-6.3+0.4-6.7-0.8-5.4

-5.5+0.5-6.0-0.8-4.7

-1.9+2.8-4.7-0.0-1.8

15d

+1.7+1.2+0.5-3.1+4.8

+2.0+5.3-3.3-3.1+5.1

+6.4+9.9-3.5-4.9+11.3

+43.9+13.1+30.8-3.2+47.2

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 50Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

J.G. Chemicals Limited reported audited standalone revenue of ₹2,889.48 million for FY2026, up 6.3% from ₹2,718.20 million in FY2025. However, net profit after tax declined 8% to ₹264.18 million from ₹287.18 million in the prior year. The auditors issued an unmodified (clean) opinion on both standalone and consolidated financial statements. The Board recommended a final dividend of 11% (₹1.10 per share). The company also disclosed that ₹42.62 million of IPO proceeds for R&D Centre setup remains unutilized and will be deployed in FY2027 due to construction delays. Cash flow from operations remained positive at ₹183.59 million (consolidated). Note 9 states previous period figures have been restated and regrouped.

Likely market impact

Revenue growth is modest at 6.3%, but the 8% decline in net profit may concern investors. The clean audit opinion and dividend recommendation are positive signals, though the unutilized IPO proceeds for R&D Centre and PAT decline warrant monitoring.